961.16(2)(b)
(b) Coca leaves and any salt, compound, derivative or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are excluded from this paragraph. [
123I]Ioflupane is excluded from this paragraph. The following substances and any of their salts, esters, isomers and salts of esters and isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
961.16(3)
(3) Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:
961.16(3)(m)
(m) Meperidine — Intermediate — A, 4-cyano-1-methyl-4- phenylpiperidine;
961.16(3)(n)
(n) Meperidine — Intermediate — B, ethyl-4-phenylpiperidine- 4-carboxylate;
961.16(3)(p)
(p) Meperidine — Intermediate — C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
961.16(3)(s)
(s) Methadone — Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane;
961.16(3)(t)
(t) Moramide — Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid;
961.16(5)
(5) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.16(7)
(7) Depressants. Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.16(8)
(8) Immediate precursors. Any material, compound, mixture or preparation which contains any quantity of the following substances:
961.16(8)(a)
(a) An immediate precursor to amphetamine or methamphetamine:
961.16(8)(b)
(b) An immediate precursor to fentanyl, including 4-anilino-N-phenethyl-4-piperidine, commonly known as ANPP.
961.16(10)(b)(b) Nabilone (another name for nabilone is (
+)-trans-3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d]pyran-9-one).
961.16 History
History: 1971 c. 219;
1981 c. 6,
206; CSB 2.16, 2.17, 2.19;
1989 a. 121; CSB 2.21;
1993 a. 98; CSB 2.22;
1995 a. 448 ss.
168 to
178,
473; Stats. 1995 s. 961.16; CSB 2.25; CSB 2.26; CSB 2.35;
2013 a. 351; CSB 2.39; CSB 2.40;
2015 a. 195 s.
83; CSB 2.44; s. 35.17 correction in (3) (zt).
961.16 Note
NOTE: See 1979-80 Statutes and 1993-94 Statutes for notes on actions by controlled substances board under s. 161.11 (1), 1993 Stats.
961.16 Annotation
At a preliminary hearing, the state must show that a substance was probably l-cocaine rather than d-cocaine. State v. Russo,
101 Wis. 2d 206,
303 N.W.2d 846 (Ct. App. 1981).
961.17
961.17
Schedule III tests. 961.17(1m)
(1m) The controlled substances board shall add a substance to schedule III upon finding that:
961.17(1m)(a)
(a) The substance has a potential for abuse less than the substances included in schedules I and II;
961.17(1m)(b)
(b) The substance has currently accepted medical use in treatment in the United States; and
961.17(1m)(c)
(c) Abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.
961.17(2m)
(2m) The controlled substances board may add a substance to schedule III without making the findings required under
sub. (1m) if the substance is controlled under schedule III of
21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.17 History
History: 1971 c. 219;
1995 a. 448 ss.
179,
180,
474; Stats. 1995 s. 961.17.
961.18
961.18
Schedule III. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule III:
961.18(2m)
(2m) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.18(3)
(3) Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.18(3)(a)
(a) Any substance which contains a derivative of barbituric acid;
961.18(3)(m)
(m) Any compound, mixture, or preparation containing any of the following drugs and one or more other active medicinal ingredients not included in any schedule:
961.18(3)(n)
(n) Any of the following drugs in suppository dosage form approved by the federal food and drug administration for marketing only as a suppository:
961.18(3)(o)
(o) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the federal food, drug and cosmetic act:
961.18(4)
(4) Other substances. Any material, compound, mixture or preparation which contains any quantity of any of the following substances, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
